Evidence map›Paper›PMID 36296773›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Liposomal Formulations Loaded with a Eugenol Derivative for Application as Insecticides: Encapsulation Studies and In Silico Identification of Protein Targets.

Maria José G Fernandes, Renato B Pereira, Ana Rita O Rodrigues, Tatiana F Vieira, A Gil Fortes, David M Pereira, Sérgio F Sousa, M Sameiro T Gonçalves, Elisabete M S Castanheira

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Maria José G FernandesCentre of Chemistry (CQUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Renato B PereiraREQUIMTE/LAQV, Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, R. Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.ORCID 0000-0001-8500-7364
Ana Rita O RodriguesPhysics Centre of Minho and Porto Universities (CF-UM-UP), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.ORCID 0000-0002-6094-1713
Tatiana F VieiraUCIBIO/REQUIMTE, BioSIM-Department of Medicine, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.ORCID 0000-0001-5137-0798
A Gil FortesCentre of Chemistry (CQUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
David M PereiraREQUIMTE/LAQV, Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, R. Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.ORCID 0000-0003-0384-7592
Sérgio F SousaUCIBIO/REQUIMTE, BioSIM-Department of Medicine, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.ORCID 0000-0002-6560-5284
M Sameiro T GonçalvesCentre of Chemistry (CQUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.ORCID 0000-0003-2048-1190
Elisabete M S CastanheiraPhysics Centre of Minho and Porto Universities (CF-UM-UP), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.ORCID 0000-0002-5829-6081
University of Minho · PTUniversidade do Porto · PT

Funding

Compete2020 POCI-01-0145-FEDER-030154FEDER POCI-01-0145-FEDER-030154Fundação para a Ciência e Tecnologia PTDC/ASP-AGR/30154/2017Fundação para a Ciência e Tecnologia PTDC/QUI-QFI/2870/2020Fundação para a Ciência e Tecnologia REDE/1517/RMN/2005Fundação para a Ciência e Tecnologia UIDB/04650/2020Fundação para a Ciência e Tecnologia UIDB/50006/2020Fundação para a Ciência e Tecnologia UID/QUI/00686/2021PRIMA Foundation H2020-PRIMA 2018-Section 2, Project MILKQUA
6 · The paper itself

Abstract

A recently synthesized new eugenol derivative, ethyl 4-(2-methoxy-4-(oxiran-2-ylmethyl)phenoxy)butanoate, with a high insecticidal activity against

Indexed as

eugenol derivativesinsecticidesinverted virtual screeningliposomal formulationsnanoencapsulationprotein targets

Identifiers

PMID36296773
PMCPMC9611868
OpenAlexW4306153475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.